Intelligent Bio Solutions Inc. Submits 510(k) Premarket Notification to FDA for Drug Screening Technology

Intelligent Bio Solutions Inc. recently announced a significant achievement as it submitted a 510(k) premarket notification to the US Food and Drug Administration (FDA) for its Intelligent Fingerprinting Drug Screening System. The submission marks a critical step towards obtaining clearance for the innovative system following FDA review, as stated in a press release issued by […]

Leave a Reply

Your email address will not be published.

Previous post iShares Short Maturity Municipal Bond Active ETF (BATS:MEAR) Reaches New 52-Week High – Here’s Why
Next post NYLI Hedge Multi-Strategy Tracker ETF (NYSEARCA:QAI) Sees Large Volume Increase – Here’s Why